RET and pheochromocytoma: MEN2A is characterized by medullary thyroid carcinoma, pheochromocytoma, and hyperparathyroidism, and MEN2B by medullary thyroid carcinoma, pheochromocytoma, ganglioneuromas, and musculoskeletal anomalies.